Download full-text PDF |
Source |
---|
Vet Anim Sci
March 2023
Department of Veterinary Sciences, University of Pisa, Italy.
Eur Heart J Case Rep
June 2018
University Hospital Zurich, Rämistrasse 100, Zurich, Switzerland.
Introduction: Management of coronary anomalies continues to be a controversial topic in medicine, for which only in specific clinical scenarios recommendations for management are clearly defined. We are presenting a previously healthy 18-year-old patient who survived sudden cardiac death (SCD). Multiple potential aetiologies were evaluated, including malignant coronary anomaly, acute myocarditis, potential Brugada type 3 electrocardiographic pattern, and urine drug screening positive for lysergic acid diethylamide (LSD).
View Article and Find Full Text PDFJ Anal Toxicol
September 2014
Department of Pathology, Center for Advanced Laboratory Medicine, University of California, San Diego Health Systems, San Diego, CA 92121, USA.
Urine drug screen (UDS) immunoassays are a quick and inexpensive method for determining the presence of drugs of abuse. Many cross-reactivities exist with other analytes, potentially causing a false-positive result in an initial drug screen. Knowledge of these potential interferents is important in determining a course of action for patient care.
View Article and Find Full Text PDFArch Pathol Lab Med
May 2010
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Context: To assist with patient diagnosis and management, physicians from pain services, drug treatment programs, and the emergency department frequently request that urine be tested for drugs of abuse. However, urine immunoassays for drugs of abuse have limitations.
Objective: To use data from the College of American Pathologists Proficiency Testing Surveys to determine and summarize the characteristics, performance, and limitations of urine immunoassays for drugs of abuse.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!